BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1388 related articles for article (PubMed ID: 25037622)

  • 21. Successful treatment of failing biological prosthesis because of "Stent creep" with valve-in-valve transcatheter aortic valve implantation.
    Attia R; Papalexopoulou N; Hancock J; Young C; Thomas M; Bapat V
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):E119-25. PubMed ID: 24550020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
    Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
    Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
    JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Edwards SAPIEN 3 valve.
    Binder RK; Rodés-Cabau J; Wood DA; Webb JG
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q83-7. PubMed ID: 22995118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balloon valuloplasty prior to transcatheter valve-in-valve implantation in a degenerated Mitroflow aortic bioprosthesis.
    Cerillo AG; Berti S; Glauber M
    Catheter Cardiovasc Interv; 2013 May; 81(6):1075-8. PubMed ID: 22744728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
    De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
    JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty.
    Bouleti C; Fassa AA; Himbert D; Brochet E; Ducrocq G; Nejjari M; Ghodbane W; Depoix JP; Nataf P; Vahanian A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):83-91. PubMed ID: 25616821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter aortic valve implantation without balloon predilation: a single-center pilot experience.
    Mendiz OA; Fraguas H; Lev GA; Valdivieso LR; Favaloro RR
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):292-7. PubMed ID: 23554013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sutureless Perceval aortic valve in comparison with the stented Carpentier-Edwards Perimount aortic valve.
    König KC; Wahlers T; Scherner M; Wippermann J
    J Heart Valve Dis; 2014 Mar; 23(2):253-8. PubMed ID: 25076560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter valve-in-valve implantation using Corevalve Revalving System for failed surgical aortic bioprostheses.
    Bedogni F; Laudisa ML; Pizzocri S; Tamburino C; Ussia GP; Petronio AS; Napodano M; Ramondo A; Presbitero P; Ettori F; Santoro G; Klugman S; De Marco F; Brambilla N; Testa L
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1228-34. PubMed ID: 22115664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position.
    Seiffert M; Franzen O; Conradi L; Baldus S; Schirmer J; Meinertz T; Reichenspurner H; Treede H
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):608-15. PubMed ID: 20506236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
    Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 2).
    Piazza N; Bleiziffer S; Brockmann G; Hendrick R; Deutsch MA; Opitz A; Mazzitelli D; Tassani-Prell P; Schreiber C; Lange R
    JACC Cardiovasc Interv; 2011 Jul; 4(7):733-42. PubMed ID: 21777880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation.
    Husser O; Holzamer A; Philipp A; Nunez J; Bodi V; Müller T; Lubnow M; Luchner A; Lunz D; Riegger GA; Schmid C; Hengstenberg C; Hilker M
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E542-51. PubMed ID: 23554044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve.
    Nombela-Franco L; Ribeiro HB; Urena M; Pasian S; Allende R; Doyle D; Delarochellière R; Delarochellière H; Laflamme L; Laflamme J; Jerez-Valero M; Côté M; Pibarot P; Larose E; Dumont E; Rodés-Cabau J
    EuroIntervention; 2014; 9(12):1398-406. PubMed ID: 24064535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
    Linke A; Woitek F; Merx MW; Schiefer C; Möbius-Winkler S; Holzhey D; Rastan A; Ender J; Walther T; Kelm M; Mohr FW; Schuler G
    Circ Cardiovasc Interv; 2012 Oct; 5(5):689-97. PubMed ID: 23048050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transapical transcatheter aortic valve implantation: follow-up to 3 years.
    Ye J; Cheung A; Lichtenstein SV; Nietlispach F; Albugami S; Masson JB; Thompson CR; Munt B; Moss R; Carere RG; Jamieson WR; Webb JG
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1107-13, 1113.e1. PubMed ID: 20412948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
    Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.